You are here

Trialling novel glucocorticoids to reduce lung diseases of preterm birth

Description 
Women who are at risk of delivering a preterm baby are given antenatal glucocorticoids to mature the lungs of the fetus before birth. However, this life-saving therapy can also impair the development of the brain and other organs. After birth, glucocorticoids are also used as anti-inflammatory agents to help wean preterm babies off ventilatory support, with similar adverse effects on the brain and other organs. This project will trial exciting new steroids in animal models of preterm birth to determine if they mature the fetal lungs and reduce postnatal lung inflammation, without adverse impacts on other organs.
Essential criteria: 
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords 
preterm birth, preterm babies, glucocorticoids, corticosteroids, respiratory distress, bronchopulmonary dysplasia, ventilation, brain injury
School 
School of Clinical Sciences at Monash Health / Hudson Institute of Medical Research
Available options 
PhD/Doctorate
Honours
BMedSc(Hons)
Time commitment 
Full-time
Top-up scholarship funding available 
No
Physical location 
Monash Medical Centre Clayton
Co-supervisors 
Prof 
Tim Cole

Want to apply for this project? Submit an Expression of Interest by clicking on Contact the researcher.